Xytis
closedBiopharmaceutical company focusing on the discovery and development of innovative central nervous system drug candidates.
| Date | Investors | Amount | Round |
|---|---|---|---|
$24.5m | Series B | ||
| Total Funding | 000k | ||
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.